ANVS phase III Alzheimer’s trial enrolled; top-line due March
ANVS says its phase III Alzheimer’s trial is fully enrolled, with top-line data expected in March and an NDA filing to follow. It also plans a $15 million raise before Q4 to fund needs.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.